Ardelyx, Inc. (ARDX)
3.28
+0.01
(+0.31%)
USD |
NASDAQ |
Oct 09, 16:00
3.275
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Cash from Operations (Quarterly) : -6.399M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.399M |
| March 31, 2026 | -32.24M |
| December 31, 2025 | 20.95M |
| September 30, 2025 | 0.365M |
| June 30, 2025 | -25.34M |
| March 31, 2025 | -38.46M |
| December 31, 2024 | 9.81M |
| September 30, 2024 | 0.501M |
| June 30, 2024 | -19.40M |
| March 31, 2024 | -35.72M |
| December 31, 2023 | -8.718M |
| September 30, 2023 | -21.47M |
| June 30, 2023 | -14.74M |
| March 31, 2023 | -44.80M |
| December 31, 2022 | 14.28M |
| September 30, 2022 | -25.43M |
| June 30, 2022 | -31.28M |
| March 31, 2022 | -27.62M |
| December 31, 2021 | -39.47M |
| September 30, 2021 | -34.59M |
| June 30, 2021 | -34.28M |
| March 31, 2021 | -44.22M |
| December 31, 2020 | -17.59M |
| September 30, 2020 | -19.88M |
| June 30, 2020 | -19.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -24.95M |
| December 31, 2019 | -11.14M |
| September 30, 2019 | -20.61M |
| June 30, 2019 | -27.82M |
| March 31, 2019 | -16.91M |
| December 31, 2018 | -18.44M |
| September 30, 2018 | -27.02M |
| June 30, 2018 | -18.02M |
| March 31, 2018 | -6.804M |
| December 31, 2017 | 4.698M |
| September 30, 2017 | -19.04M |
| June 30, 2017 | -24.09M |
| March 31, 2017 | -26.76M |
| December 31, 2016 | -26.56M |
| September 30, 2016 | -24.82M |
| June 30, 2016 | -24.90M |
| March 31, 2016 | -16.25M |
| December 31, 2015 | -21.60M |
| September 30, 2015 | -11.80M |
| June 30, 2015 | -30.22M |
| March 31, 2015 | -8.209M |
| December 31, 2014 | -3.792M |
| September 30, 2014 | -5.685M |
| June 30, 2014 | |
| March 31, 2014 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -31.49M |
| REGENXBIO, Inc. | -62.24M |
| Compass Therapeutics, Inc. | -14.74M |
| ARS Pharmaceuticals, Inc. | -60.93M |
| Sionna Therapeutics, Inc. | -22.22M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 22.66M |
| Cash from Financing (Quarterly) | 49.72M |
| Free Cash Flow | -17.92M |
| Free Cash Flow Per Share (Quarterly) | -0.0258 |
| Free Cash Flow to Equity (Quarterly) | -54.34M |
| Free Cash Flow to Firm (Quarterly) | -0.1468M |
| Free Cash Flow Yield | -2.23% |